🔎 Trials Near Me

Utama › Penyakit Crohn › Florida › Orlando

Kajian klinikal Penyakit Crohn di Orlando, FL

17 kajian untuk Penyakit Crohn sedang mencari peserta di lokasi dalam dan sekitar Orlando (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Mengambil pesertaFasa 3
  • AdventHealth Orlando ( Site 5131), Orlando
  • Endoscopic Research Inc ( Site 5061), Orlando
Umur 16 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Mengambil pesertaFasa 2
  • Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
  • Clinical Research of Osceola /ID# 280593, Kissimmee · 16 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Mengambil pesertaFasa 4
  • Endoscopic Research, Inc., Orlando
  • Orlando Health-Orlando Regional Medical Center, Orlando
  • Digestive and Liver Center of Florida, P.A., Kissimmee · 16 mi jauh
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Mengambil pesertaFasa 2
  • Endoscopic Research, Inc. /ID# 267211, Orlando
  • Novum Research /ID# 278128, Clermont · 24 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 2
  • AdventHealth (Florida Hospital) Medical Group, Orlando
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Mengambil pesertaFasa 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • AdventHealth Orlando-Site Number: 8400070, Orlando
  • Orlando Health, Inc.-Site Number: 8400084, Orlando
  • Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi jauh
  • dan 1 lagi
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
  • Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 mi jauh
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184944

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
Umur 2 hingga 17 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05995353

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 2
  • Endoscopic Research Inc, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi jauh
Umur 18 hingga 85 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Mengambil pesertaFasa 4
  • Endoscopic Research Inc, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi jauh
Umur 18 hingga 70 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Mengambil peserta
  • Advent Health, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Mengambil pesertaKajian pemerhatian
  • AdventHealth, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07237516

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Mengambil pesertaFasa 4
  • Digestive & Liver Center of Florida, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06997965

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 2
  • Orlando Health, Inc., Orlando
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Apr 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Mengambil pesertaFasa 2
  • Investigational Site Number: 8400007, Orlando
  • Investigational Site Number: 8400017, Kissimmee · 16 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mengambil pesertaFasa 2
  • Mirador Therapeutics Selected Site, Orlando
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT07113522

Kajian Penyakit Crohn di bandar lain

Kajian lain di Orlando

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.